What does DR PETRA NIJST - CARDIOLOGIE do?

DR PETRA NIJST - CARDIOLOGIE is a specialist medical practice in Lanaken. Private Limited, started on 14 July 2020, 1 establishment.

What is the address of DR PETRA NIJST - CARDIOLOGIE?

The registered office of DR PETRA NIJST - CARDIOLOGIE is located at Eekhoornlaan 25, 3621 Lanaken.

Is DR PETRA NIJST - CARDIOLOGIE still active?

Yes. According to the CBE (30 September 2026) DR PETRA NIJST - CARDIOLOGIE is active, legal situation “Normale toestand”, started on 14 July 2020.

Is DR PETRA NIJST - CARDIOLOGIE registered on Peppol?

Yes, DR PETRA NIJST - CARDIOLOGIE is registered on the Peppol network with ID 0208:0750648455.

What is the enterprise number of DR PETRA NIJST - CARDIOLOGIE?

The enterprise number of DR PETRA NIJST - CARDIOLOGIE is BE0750648455.

When was DR PETRA NIJST - CARDIOLOGIE founded?

DR PETRA NIJST - CARDIOLOGIE was founded on 14 July 2020.

Who are the directors of DR PETRA NIJST - CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DR PETRA NIJST - CARDIOLOGIE are: Petra Nijst.

Is DR PETRA NIJST - CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 July 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR PETRA NIJST - CARDIOLOGIE make in 2025?

DR PETRA NIJST - CARDIOLOGIE posted a profit after taxes of € 501,706 in financial year 2025.

What is the revenue of DR PETRA NIJST - CARDIOLOGIE?

As a small company, DR PETRA NIJST - CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 698,057.

DR PETRA NIJST - CARDIOLOGIE (Private Limited) - Lanaken

Dossier DR PETRA NIJST - CARDIOLOGIE, printed on 30 September 2026 from databakkes.be/en/0750648455/dr-petra-nijst-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR PETRA NIJST - CARDIOLOGIE from Lanaken, company number BE0750648455, closed financial year 2025 with a result of € 501,706 after tax. For that financial year DR PETRA NIJST - CARDIOLOGIE recorded a gross margin of € 698,057 and equity of € 504,706. Compared with financial year 2024, the result moved from € 331,792 to € 501,706. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 504,706

▼ 33% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 501,706

▲ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 330,538

▼ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 750,514 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 61,069

▲ € 55,994 vs 2024

Of which on lease € 31,911.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,046

€ 10,623 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 24,504

▲ 41% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 194,970

▲ € 179,664 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 411,619 Gross margin 2022: € 411,619 First fiscal year in the series	€ 433,823 Gross margin 2023: € 433,823 ▲ 5% vs 2022 (€ 411,619) Favourable step	€ 437,952 Gross margin 2024: € 437,952 ▲ 1% vs 2023 (€ 433,823) Favourable step	€ 698,057 Gross margin 2025: € 698,057 ▲ 59% vs 2024 (€ 437,952) Favourable step	▲ 59%
Profit after taxes	€ 310,047 Profit after taxes 2022: € 310,047 First fiscal year in the series	€ 326,599 Profit after taxes 2023: € 326,599 ▲ 5% vs 2022 (€ 310,047) Favourable step	€ 331,792 Profit after taxes 2024: € 331,792 ▲ 2% vs 2023 (€ 326,599) Favourable step	€ 501,706 Profit after taxes 2025: € 501,706 ▲ 51% vs 2024 (€ 331,792) Favourable step	▲ 51%
Equity	€ 683,358 Equity 2022: € 683,358 First fiscal year in the series	€ 1,009,958 Equity 2023: € 1,009,958 ▲ 48% vs 2022 (€ 683,358) Favourable step	€ 753,514 Equity 2024: € 753,514 ▼ 25% vs 2023 (€ 1,009,958) Unfavourable step	€ 504,706 Equity 2025: € 504,706 ▼ 33% vs 2024 (€ 753,514) Unfavourable step	▼ 33%
Total debts	€ 114,046 Total debts 2022: € 114,046 First fiscal year in the series	€ 34,476 Total debts 2023: € 34,476 ▼ 70% vs 2022 (€ 114,046) Favourable step	€ 50,831 Total debts 2024: € 50,831 ▲ 47% vs 2023 (€ 34,476) Unfavourable step	€ 272,756 Total debts 2025: € 272,756 ▲ € 221,925 vs 2024 (€ 50,831) Unfavourable step	▲ € 221,925
Cash	€ 495,724 Cash 2022: € 495,724 First fiscal year in the series	€ 95,417 Cash 2023: € 95,417 ▼ 81% vs 2022 (€ 495,724) Unfavourable step	€ 403,818 Cash 2024: € 403,818 ▲ € 308,402 vs 2023 (€ 95,417) Favourable step	€ 330,538 Cash 2025: € 330,538 ▼ 18% vs 2024 (€ 403,818) Unfavourable step	▼ 18%
Retained profit	€ 680,358 Retained profit 2022: € 680,358 First fiscal year in the series	€ 1,006,958 Retained profit 2023: € 1,006,958 ▲ 48% vs 2022 (€ 680,358) Favourable step	€ 750,514 Retained profit 2024: € 750,514 ▼ 25% vs 2023 (€ 1,006,958) Unfavourable step	€ 501,706 Retained profit 2025: € 501,706 ▼ 33% vs 2024 (€ 750,514) Unfavourable step	▼ 33%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 588,235 Dividend 2024: € 588,235 Unchanged (€ 0) Unchanged	€ 750,514 Dividend 2025: € 750,514 ▲ 28% vs 2024 (€ 588,235) Unchanged	▲ 28%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 33,046 Bank debt 2025: € 33,046 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 797,404 Balance sheet total 2022: € 797,404 First fiscal year in the series	€ 1,044,434 Balance sheet total 2023: € 1,044,434 ▲ 31% vs 2022 (€ 797,404) Unchanged	€ 804,345 Balance sheet total 2024: € 804,345 ▼ 23% vs 2023 (€ 1,044,434) Unchanged	€ 777,462 Balance sheet total 2025: € 777,462 ▼ 3% vs 2024 (€ 804,345) Unchanged	▼ 3%

Key figures of DR PETRA NIJST - CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR PETRA NIJST - CARDIOLOGIE?

What happened at DR PETRA NIJST - CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 501,706 (▲ 51% vs 2024). filed late Source: NBB ↗
Jul 14, 2020 New establishment in Genk. KBO
2020 Petra Nijst became a director. NBB
Jul 14, 2020 Start of the company according to the CBE. KBO

In short

From € 310,047 profit in 2022 to € 501,706 profit in 2025.

Paid € 475,518 in corporate taxes since 2022.

Best year ever: 2025, with € 501,706 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR PETRA NIJST - CARDIOLOGIE? We notify you, reason included.

Follow DR PETRA NIJST - CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Petra Nijst

DR PETRA NIJST - CARDIOLOGIE

Matthias Dupont 5%

Behind DR PETRA NIJST - CARDIOLOGIE is Petra Nijst. It owns 5% of Matthias Dupont itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Petra Nijst

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Eekhoornlaan 25

3621 Lanaken

2.306.625.554

Schiepse Bos 6

3600 Genk

Active since 14 July 2020

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0750.648.455
VAT number: BE 0750.648.455
Registered office: Eekhoornlaan 25, 3621 Lanaken
Names & denominations: DR PETRA NIJST - CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 July 2020
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗